FDA announces changes in drug center?s oncology office
Today, the U.S. Food and Drug Administration announced organizational changes within the office responsible for reviewing all drug and biologic applications for cancer therapies. The Center for Drug Evaluation and Research?s (CDER) Office of Oncology Drug Products has been reorganized...
Sep 12th, 2011
FDA announces changes in drug centers